. 2019 Oct 22;15:358. doi: 10.1186/s12917-019-2087-2

Table 9.

Clinical trials carried out with mesenchymal stem cells in feline asthma

Species (number)	Treatment	Results	Conclusion	Reference
Cat (6) Acute asthma	Five IV allogeneic ASCs (varied between 2 × 10⁶ and 1 x 10⁷per cat)	Decreased in: airway eosinophilia, hyper-responsiveness and airway remodeling	ASCs therapy had a positive effect on airway remodeling	[71]
Cat (9) Chronic asthma	Six IV allogeneic ASCs (with range amplitude of 0.36–2.5 × 10⁷ MSCs/infusion)	Decreased in airway remodeling	ASCs therapy had a positive effect on airway remodeling	[79]